This recent outperformance of Boston Scientific can partly be attributed to its announcement to acquire Apollo Endosurgery in a $615 million deal.
This recent outperformance of Boston Scientific can partly be attributed to its announcement to acquire Apollo Endosurgery in a $615 million deal.